STAAR Surgical Company STAA
NASDAQ
| 10/02/2026 | 07/03/2026 | 04/03/2026 | 01/02/2026 | 09/26/2025 | |
|---|---|---|---|---|---|
| Net Income | -37.25% | 147.93% | 109.60% | 46.51% | -10.98% |
| Total Depreciation and Amortization | 21.70% | 21.01% | -9.84% | -15.49% | 13.83% |
| Total Amortization of Deferred Charges | 811.54% | 545.58% | 96.23% | -- | -- |
| Total Other Non-Cash Items | -87.45% | 352.29% | -23.58% | 40.13% | 98.68% |
| Change in Net Operating Assets | 150.26% | 82.09% | -250.72% | -96.24% | -60.21% |
| Cash from Operations | 924.18% | 172.26% | -278.36% | -709.66% | -30.11% |
| Capital Expenditure | -5.89% | 72.43% | 69.82% | 70.71% | 85.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -744.39% | -103.24% | -92.97% | -28.82% | 121.25% |
| Cash from Investing | -869.79% | -105.44% | -93.93% | 0.41% | 114.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -99.87% | 10,225.00% | -53.85% | 185.00% | 78.94% |
| Repurchase of Common Stock | 33.25% | 39.78% | -45.52% | -50.46% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -234.18% | 66.92% | -78.59% | 54.55% | -39.13% |
| Foreign Exchange rate Adjustments | -426.37% | -115.60% | -115.73% | 142.45% | -91.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -265.88% | 379.37% | -173.51% | -15.93% | 131.36% |